This week in psychedelic stock news, there are big patent developments for Compass, MindMed and Numinus.
The post This Week in Psychedelic Stocks: Compass Pathways Wins Patent Battle, MindMed Patents Candy Flipping, and More! appeared first on Psychedelic Spotlight.
Compass Pathways Psilocybin Patent Upheld
Compass Pathways scores a major victory in their bid to patent Comp 360, a proprietary formulation of psilocybin.
The post Compass Pathways Psilocybin Patent Upheld appeared first on Psychedelic Spotlight.
Jon Stewart Admits to Week Long Mushroom Binge before Comedy Set
Joh Stewart, comedian and former host of “The Daily Show,” drops a shroom bomb in a recent podcast interview.
The post Jon Stewart Admits to Week Long Mushroom Binge before Comedy Set appeared first on Psychedelic Spotlight.
I Tried 5-MeO-DMT at a Psychedelic Retreat. This is MY Story
Have you ever considered taking 5-MeO-DMT, also known as Bufo Alvarius? If so, this video is for you. Swati Sharma, Media Director of PsychedelicSpotlight.com sits down with James Hallifax to discuss her recent psychedelic experience. She traveled to Tepotzlan, Mexico to partake in a psychedelic ceremony, where participants took the psychedelic substance. Was she healed […]
The post I Tried 5-MeO-DMT at a Psychedelic Retreat. This is MY Story appeared first on Psychedelic Spotlight.
The Great Microdosing Debate
Microdosing psychedelics is more popular than ever, but is there any evidence that it works? We unpack the great microdosing debate.
The post The Great Microdosing Debate appeared first on Psychedelic Spotlight.
Psilocybin as an Agent for Human and Cultural Development with Jahan Khamsehzadeh Ph.D.
In this episode, Dr. Khamsehzadeh delves into our historical and ancestral relationship to psilocybin and theorizes how mushrooms have impacted the development of the brain.
The post Psilocybin as an Agent for Human and Cultural Development with Jahan Khamsehzadeh Ph.D. appeared first on Psychedelic Spotlight.
AI Interview on Psychedelics
There is growing interest in AI’s ability to mimic human interactions. We interview OpenAI’s GPT-3 chatbot to see what it knows about psychedelics.
The post AI Interview on Psychedelics appeared first on Psychedelic Spotlight.
SPOTLIGHT IN FOCUS – The Rise of Psychedelic Therapy
Dr. Zinia Thomas at Radiance Wellness, St. Louis MO – Dr. Zinia Thomas is a psychiatrist whose interest in utilizing the power of psychedelics to promote mental wellness and recovery in her patients with treatment-resistant depression and substance use disorder was peaked long before she began to utilize IV Ketamine as a therapeutic in her […]
The post SPOTLIGHT IN FOCUS – The Rise of Psychedelic Therapy appeared first on Psychedelic Spotlight.
Can Ketamine Therapy Be the Solution for Treatment Resistant Depression & Opioid Addiction?
Ketamine therapy is shaping up to be one of the best legally available treatments to relieve a wide range of mental health issues such as PTSD, addiction, depression and suicidal thoughts. Ketamine’s origin story begins in the 1960s, where it was first synthesized as an anaesthetic for animals. A decade later, the FDA approved the […]
The post Can Ketamine Therapy Be the Solution for Treatment Resistant Depression & Opioid Addiction? appeared first on Psychedelic Spotlight.
DMT is Effective at Treating Depression, New Study Finds
DMT is a powerful hallucinogen that can conjure visions of entities and alien worlds, but new research shows it can also treat depression.
The post DMT is Effective at Treating Depression, New Study Finds appeared first on Psychedelic Spotlight.